Investor Relations

Profile and News

Company Profile

We harness our breakthrough platform to develop and produce affordable RNA for human therapies and agriculture.

PRESS RELEASE

GreenLight Biosciences to become a public company

SEC FILINGS

GreenLight Biosciences to merge with Environmental Impact Acquisition Corp.

INVESTOR DECK

We are dedicated to making RNA products affordable and accessible


GreenLight featured in…